Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
saquinavir
|
| gptkbp:approvalYear |
1997
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J05AE01
|
| gptkbp:brand |
saquinavir
|
| gptkbp:contraindication |
severe hepatic impairment
hypersensitivity to saquinavir |
| gptkbp:discontinued |
2006
|
| gptkbp:drugClass |
protease inhibitor
|
| gptkbp:form |
soft gelatin capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fortovase
|
| gptkbp:indication |
treatment of HIV-1 infection
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:market |
discontinued
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:replacedBy |
gptkb:Invirase
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain dyspepsia lipodystrophy |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:Saquinavir
|
| gptkbp:bfsLayer |
7
|